Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008;3(4):803-14.
doi: 10.2147/copd.s4257.

Geographic differences in clinical characteristics and management of COPD: the EPOCA study

Marc Miravitlles  1 , Cristina Murio, Gema Tirado-Conde, Gur Levy, Hana Muellerova, Joan B Soriano, Alejandra Ramirez-Venegas, Fanny W S Ko, Byron Canelos-Estrella, Eduardo Giugno, Miguel Bergna, Ivan Chérrez, Antonio Anzueto
Affiliations
Comparative Study

Geographic differences in clinical characteristics and management of COPD: the EPOCA study

Marc Miravitlles et al. Int J Chron Obstruct Pulmon Dis. 2008.

Abstract

Aims: Data on differences in clinical characteristics and management of COPD in different countries and settings are limited. We aimed to characterize the profile of patients with COPD in a number of countries and their treatment in order to evaluate adherence to recommendations of international guidelines.

Method: This was an observational, international, cross-sectional study on patients with physician-diagnosed COPD. Demographic and clinical characteristics, risk factors, and treatment were collected by their physician via an internet web-based questionnaire developed for the study.

Results: A total of 77 investigators from 17 countries provided data on 833 patients. The countries with the highest number of patients included were: Argentina (128), Ecuador (134), Spain (162), and Hong Kong (153). Overall, 79.3% were men and 81% former smokers, with a mean FEV1 = 42.7%, ranging from 34.3% in Hong Kong to 58.8% in Ecuador. Patients reported a mean of 1.6 exacerbations the previous year, with this frequency being significantly and negatively correlated with FEV1 (%) (r = -0.256; p < 0.0001). Treatment with short-acting bronchodilators and theophyllines was more frequent in Ecuador and Hong Kong compared with Spain and Argentina, and in patients belonging to lower socioeconomic levels (p < 0.0001 for all comparisons). Inadequacy of treatment with inhaled corticosteroids and theophyllines was high, with significant differences among countries.

Conclusions: Differences in the clinical characteristics and management of COPD were significant across countries. Adherence to international guidelines appears to be low. Efforts should be made to disseminate and adapt guidelines to the socioeconomic reality of different settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between lung function (FEV1(%)) and the frequency of exacerbations the previous year (r = −0.256; p < 0.0001).
See this image and copyright information in PMC

References

    1. Adams SG, Anzueto A, Pugh JA, et al. Mexican American elders have similar severities of COPD despite less tobacco exposure thank European American elders. Respir Med. 2006;100:1966–72. - PubMed
    1. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–36. - PubMed
    1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD study): a population-based prevalence study. Lancet. 2007;370:741–50. - PubMed
    1. Burge S, Wedzicha JA. COPD exacerbations: definitions and classification. Eur Respir J. 2003;21:46–53. - PubMed
    1. Calverley PMA, Anderson JA, Celli B, Ferguson GT, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–89. - PubMed

Publication types

MeSH terms